Study on Mavorixafor for Patients with Chronic Neutropenia Experiencing Recurrent or Serious Infections
- Substances:Mavorixafor
Greece- Participants:0–17 years · 18–64 years · 65+ years
- Substances:Mavorixafor
- Sponsor:X4 Pharmaceuticals Inc.
Rare diseases
Investigational molecules
Locations
Back to Greece244 clinical trials in Heraklion, Greece across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Greece
Greece
Greece
Greece
Greece
Greece
Greece
Greece
Greece
Greece
Greece
GreeceThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on systemic lupus erythematosus and cutaneous lupus, evaluating novel therapeutic approaches. Studies aim to assess treatment effectiveness and long-term safety profiles.
Multiple trials exploring innovative medications for chronic autoimmune conditions.
Comprehensive studies investigating treatments for inflammatory bowel diseases, including trials for both mild and severe cases. Research focuses on combination therapies and long-term management strategies.
Advanced therapeutic approaches for chronic digestive conditions.
Innovative trials targeting various forms of lung cancer and breast cancer, with a focus on advanced and metastatic disease states. Studies evaluate new combination therapies and treatment approaches.
Exploring breakthrough treatments in cancer care.
Tell us about your condition – we search every trial in Europe and connect you with the right site.